Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	6.64e-08	11	219	5	GO:0004523
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 DHX9 ERVK-11 ERVK-8	7.69e-08	21	219	6	GO:0035613
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 BACE1 ERVK-7 ERVK-10 ERVK-18 ERVK-25 ERVK-8	1.35e-07	37	219	7	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 BACE1 ERVK-7 ERVK-10 ERVK-18 ERVK-25 ERVK-8	1.64e-07	38	219	7	GO:0070001
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	2.80e-07	14	219	5	GO:0003964
GeneOntologyMolecularFunction	triplex DNA binding	DHX9 DDX11 DDX12P	5.16e-06	4	219	3	GO:0045142
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 RNASE2 AGO1 ERVK-8	2.57e-05	79	219	7	GO:0004521
GeneOntologyMolecularFunction	DNA replication origin binding	DHX9 DDX11 DDX12P ORC4	3.82e-05	18	219	4	GO:0003688
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	4.96e-05	37	219	5	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	5.67e-05	38	219	5	GO:0034061
GeneOntologyMolecularFunction	lipoprotein particle receptor binding	RELN SNX17 DAB2 HSPG2 APOB	6.44e-05	39	219	5	GO:0070325
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA2 ABCA13 ATP9B DHX9 DDX11 DDX60L DNAH3 DDX12P DHX57 ORC4 ABCB10 ABCB11 ATP2B2 FIGNL1 ATP2B4	1.13e-04	441	219	15	GO:0016887
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	1.44e-04	46	219	5	GO:0016893
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA2 ABCA13 TMEM94 ABCB10 ABCB11 ATP2B2 ATP2B4	2.01e-04	109	219	7	GO:0042626
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA2 ABCA13 TMEM94 ACSS1 ATP9B DHX9 DDX11 DDX60L DNAH3 DDX12P DHX57 ORC4 ABCB10 ABCB11 ATP2B2 FIGNL1 ATP2B4	4.57e-04	614	219	17	GO:0140657
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor binding	SNX17 DAB2 HSPG2 APOB	5.04e-04	34	219	4	GO:0050750
GeneOntologyMolecularFunction	catalytic activity, acting on RNA	ERVK-6 ERVK-7 ERVK-10 DHX9 DDX60L ERVK-11 DXO DDX12P DUS4L DHX57 RNASE2 AGO1 ERVK-8	7.33e-04	417	219	13	GO:0140098
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 RNASE2 AGO1 ERVK-8	7.66e-04	136	219	7	GO:0004540
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-11 RNASE2 AGO1 ERVK-8	7.66e-04	136	219	7	GO:0004519
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8	1.55e-07	13	219	5	GO:0015074
MousePheno	abnormal atrioventricular valve morphology	IFT140 NF1 CC2D2A IGF2R DAW1 ARID2 DCHS1	1.34e-05	69	160	7	MP:0002745
MousePheno	abnormal neural tube morphology	IFT140 USP9X BBS4 ADAR DDX11 FREM2 NF1 WNT3A CC2D2A KDR MED23 DNMT1 RAF1 ISYNA1 DDX12P RTTN ELP1 TFAP2A CELSR1 DCHS1	1.37e-05	591	160	20	MP:0002151
MousePheno	abnormal heart valve morphology	IFT140 FREM2 NF1 CC2D2A HSPG2 TFAP2A IGF2R DAW1 ARID2 DCHS1	1.79e-05	163	160	10	MP:0000285
MousePheno	abnormal heart atrium and ventricle connection	IFT140 NF1 CC2D2A IGF2R DAW1 ARID2 DCHS1	2.33e-05	75	160	7	MP:0010435
MousePheno	abnormal mechanoreceptor morphology	BACE1 BBS4 TSHR CC2D2A USH2A ELP1 CELSR1 SCARB2 DCHS1 ATP2B2 OTOG	7.08e-05	231	160	11	MP:0000972
MousePheno	abnormal nervous system development	IFT140 ARHGAP32 RELN TMEM94 USP9X CCNO BBS4 ADAR DDX11 FREM2 NF1 WNT3A CC2D2A KDR MED23 WASF1 DNMT1 RAF1 HSPG2 ISYNA1 DDX12P RTTN ELP1 APOB TFAP2A CELSR1 DCHS1 PAX6 ATP2B2 HYDIN	8.20e-05	1257	160	30	MP:0003861
MousePheno	persistent truncus arteriosus	IFT140 SNX17 NF1 CC2D2A CARM1 TFAP2A	1.15e-04	67	160	6	MP:0002633
MousePheno	abnormal aorticopulmonary septum morphology	IFT140 SNX17 NF1 CC2D2A CARM1 TFAP2A	1.25e-04	68	160	6	MP:0010650
MousePheno	aorticopulmonary septal defect	IFT140 SNX17 NF1 CC2D2A CARM1 TFAP2A	1.25e-04	68	160	6	MP:0010651
MousePheno	impaired cranial neural crest cell differentiation	KDR MED23	1.30e-04	2	160	2	MP:0012756
MousePheno	abnormal cardiac outflow tract development	IFT140 SNX17 NF1 CC2D2A CARM1 HSPG2 ELP1 TFAP2A	1.52e-04	134	160	8	MP:0006126
Domain	LAM_G_DOMAIN	USH2A HSPG2 FAT3 EYS CELSR1 CNTNAP2	3.44e-06	38	206	6	PS50025
Domain	Laminin_G_2	USH2A HSPG2 FAT3 EYS CELSR1 CNTNAP2	4.70e-06	40	206	6	PF02210
Domain	LamG	USH2A HSPG2 FAT3 EYS CELSR1 CNTNAP2	8.33e-06	44	206	6	SM00282
Domain	ConA-like_dom	ADGRG4 RYR1 BTN3A3 BTN2A2 USH2A HSPG2 FAT3 FSD1 EYS CELSR1 CNTNAP2	3.29e-05	219	206	11	IPR013320
Domain	Laminin_G	USH2A HSPG2 FAT3 EYS CELSR1 CNTNAP2	4.20e-05	58	206	6	IPR001791
Domain	EGF_3	RELN SSPOP HSPG2 STAB2 HYAL1 FAT3 EYS CELSR1 CNTNAP2 MUC4 OTOG	6.25e-05	235	206	11	PS50026
Domain	-	ADGRG4 USH2A HSPG2 FAT3 EYS CELSR1 CNTNAP2	8.72e-05	95	206	7	2.60.120.200
Domain	EGF_1	RELN SSPOP USH2A HSPG2 STAB2 HYAL1 FAT3 EYS CELSR1 CNTNAP2 MUC4	1.29e-04	255	206	11	PS00022
Domain	EGF	RELN GPR179 HSPG2 STAB2 HYAL1 FAT3 EYS CELSR1 CNTNAP2 MUC4	2.91e-04	235	206	10	SM00181
Domain	EGF_LAM_2	USH2A HSPG2 STAB2 CELSR1	3.15e-04	30	206	4	PS50027
Domain	EGF_LAM_1	USH2A HSPG2 STAB2 CELSR1	3.15e-04	30	206	4	PS01248
Domain	EGF-like_dom	RELN HSPG2 STAB2 HYAL1 FAT3 EYS CELSR1 CNTNAP2 MUC4 OTOG	4.60e-04	249	206	10	IPR000742
Domain	N2O_reductase_N	PEX7 FZR1 WDR17	5.46e-04	15	206	3	IPR011045
Domain	EGF_Lam	USH2A HSPG2 STAB2 CELSR1	5.76e-04	35	206	4	SM00180
Domain	TSP_1	ADGRB3 SSPOP THSD7B ADAMTS12 ADAMTS10	6.50e-04	63	206	5	PF00090
Domain	VWF_type-D	SSPOP MUC4 OTOG	6.66e-04	16	206	3	IPR001846
Domain	VWFD	SSPOP MUC4 OTOG	6.66e-04	16	206	3	PS51233
Domain	ATPase_P-typ_TM_dom	TMEM94 ATP2B2 ATP2B4	6.66e-04	16	206	3	IPR023298
Domain	VWD	SSPOP MUC4 OTOG	6.66e-04	16	206	3	SM00216
Domain	-	TMEM94 ATP2B2 ATP2B4	6.66e-04	16	206	3	1.20.1110.10
Domain	VWD	SSPOP MUC4 OTOG	6.66e-04	16	206	3	PF00094
Domain	ATPase_P-typ_transduc_dom_A	TMEM94 ATP9B ATP2B2 ATP2B4	7.14e-04	37	206	4	IPR008250
Domain	E1-E2_ATPase	TMEM94 ATP9B ATP2B2 ATP2B4	7.14e-04	37	206	4	PF00122
Domain	ATP_Ca_trans_C	ATP2B2 ATP2B4	7.16e-04	4	206	2	IPR022141
Domain	ATP_Ca_trans_C	ATP2B2 ATP2B4	7.16e-04	4	206	2	PF12424
Domain	P-type_ATPase_IIB	ATP2B2 ATP2B4	7.16e-04	4	206	2	IPR006408
Domain	EGF_2	RELN SSPOP HSPG2 STAB2 HYAL1 FAT3 EYS CELSR1 CNTNAP2 MUC4	7.45e-04	265	206	10	PS01186
Domain	TSP1	ADGRB3 SSPOP THSD7B ADAMTS12 ADAMTS10	7.51e-04	65	206	5	SM00209
Domain	TSP1_rpt	ADGRB3 SSPOP THSD7B ADAMTS12 ADAMTS10	7.51e-04	65	206	5	IPR000884
Domain	TSP1	ADGRB3 SSPOP THSD7B ADAMTS12 ADAMTS10	7.51e-04	65	206	5	PS50092
Domain	Laminin_EGF	USH2A HSPG2 STAB2 CELSR1	7.91e-04	38	206	4	IPR002049
Domain	ATPase_P-typ_cation-transptr_C	TMEM94 ATP2B2 ATP2B4	8.02e-04	17	206	3	IPR006068
Domain	Cation_ATPase_C	TMEM94 ATP2B2 ATP2B4	8.02e-04	17	206	3	PF00689
Domain	AAA	ABCA2 ABCA13 DNAH3 ORC4 ABCB10 ABCB11 FIGNL1	1.10e-03	144	206	7	SM00382
Domain	AAA+_ATPase	ABCA2 ABCA13 DNAH3 ORC4 ABCB10 ABCB11 FIGNL1	1.10e-03	144	206	7	IPR003593
Domain	MFS	SLCO1B3 SLC22A24 SLC49A3 SLC22A20P SLC17A9 SLC22A2	1.26e-03	108	206	6	PS50850
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IFT140 ABCA2 SNX17 ADGRB3 ZNF608 TECPR2 SERINC1 MED23 DOCK6 AKAP6 XPO4 SPG11 NPEPL1 TUBGCP6 IBTK CNTNAP2	3.76e-07	529	223	16	14621295
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10	1.04e-06	4	223	3	10469592
Pubmed	Extra-embryonic-specific imprinted expression is restricted to defined lineages in the post-implantation embryo.	KDR DNMT1 IGF2R SLC22A2	1.12e-06	13	223	4	21354127
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18	2.58e-06	5	223	3	12629516
Pubmed	Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice.	PDE4A PANX1 DNMT1	2.58e-06	5	223	3	26573818
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-25 ERVK-11 ERVK-8	2.59e-06	94	223	7	21542922
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GALK1 USP9X MED14 ADAR GTF3C4 STAT1 MED23 DNMT1 SPAG9 TFAP2A PHF3 ARID2 DOCK7 PRKDC HCFC1	3.06e-06	549	223	15	38280479
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FREM2 WASF1 FAT3 CELSR1 DCHS1 PRKDC	4.68e-06	67	223	6	21875946
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-10 ERVK-18 ERVK-25 ERVK-11	4.69e-06	18	223	4	18664271
Pubmed	The cluster of BTN genes in the extended major histocompatibility complex.	BTN3A3 BTN2A2 BTN3A2	8.93e-06	7	223	3	11170752
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADGRB3 SSPOP KDR THSD7B ADAMTS12 ADAMTS10	9.04e-06	75	223	6	20637190
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 PDE4A MORN1 TMEM94 MED14 PANX1 ADCY7 RYR1 FZR1 ZMIZ2 DOCK6 SEMA6B HSPG2 RTTN BTN3A2 CELSR1 IGF2R ZNF341 ZNF335 PRKDC HCFC1	1.02e-05	1105	223	21	35748872
Pubmed	Dentate Gyrus Development Requires ERK Activity to Maintain Progenitor Population and MAPK Pathway Feedback Regulation.	RELN WNT3A RAF1 PAX6	1.10e-05	22	223	4	25926459
Pubmed	Vigilins bind to promiscuously A-to-I-edited RNAs and are involved in the formation of heterochromatin.	ADAR DHX9 PRKDC	1.42e-05	8	223	3	15723802
Pubmed	Ascl1 participates in Cajal-Retzius cell development in the neocortex.	RELN WNT3A PAX6	1.42e-05	8	223	3	21467208
Pubmed	Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis.	KDR TFAP2A PAX6	1.42e-05	8	223	3	18653562
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	RELN ASPN SSPOP SEMA6D HSPG2 COL6A1 MUC4 HCFC1	1.87e-05	175	223	8	28071719
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	IFT140 ARHGAP32 ABCA2 SSPOP MED23 THSD7B CNTNAP2	2.20e-05	130	223	7	12421765
Pubmed	Lateral Thalamic Eminence: A Novel Origin for mGluR1/Lot Cells.	RELN WNT3A TFAP2A PAX6	2.99e-05	28	223	4	27178193
Pubmed	Transient Fcho1/2⋅Eps15/R⋅AP-2 Nanoclusters Prime the AP-2 Clathrin Adaptor for Cargo Binding.	DAB2 ITSN1 TFAP2A	3.02e-05	10	223	3	27237791
Pubmed	Repurposing of the multiciliation gene regulatory network in fate specification of Cajal-Retzius neurons.	RELN CCNO WNT3A HTR2C	3.96e-05	30	223	4	37321213
Pubmed	Localization and behaviors in null mice suggest that ASIC1 and ASIC2 modulate responses to aversive stimuli.	ASIC2 ASIC1	4.09e-05	2	223	2	24256442
Pubmed	Acid-sensing ion channel-1b in the stereocilia of mammalian cochlear hair cells.	ASIC2 ASIC1	4.09e-05	2	223	2	16951561
Pubmed	Acid-Sensing Ion Channel 1a Contributes to Airway Hyperreactivity in Mice.	ASIC2 ASIC1	4.09e-05	2	223	2	27820848
Pubmed	BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels.	ASIC2 ASIC1	4.09e-05	2	223	2	9037075
Pubmed	Upregulation of acid-sensing ion channel 1 protein expression by chronic administration of cocaine in the mouse striatum in vivo.	ASIC2 ASIC1	4.09e-05	2	223	2	19427358
Pubmed	Lipid-mediated phase separation of AGO proteins on the ER controls nascent-peptide ubiquitination.	AGO1 LTN1	4.09e-05	2	223	2	35325613
Pubmed	A proteomic approach to evaluate the butyrophilin gene family expression in human milk fat globule membrane.	BTN2A2 BTN3A2	4.09e-05	2	223	2	12124930
Pubmed	Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells.	STAT1 KDR	4.09e-05	2	223	2	10961983
Pubmed	Differential localization of Acid-sensing ion channels 1 and 2 in human cutaneus pacinian corpuscles.	ASIC2 ASIC1	4.09e-05	2	223	2	20306292
Pubmed	Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.	TFAP2A MUC4	4.09e-05	2	223	2	17621592
Pubmed	Structure and evolution of the extended B7 family.	BTN3A3 BTN2A2	4.09e-05	2	223	2	10354554
Pubmed	Presynaptic release probability is increased in hippocampal neurons from ASIC1 knockout mice.	ASIC2 ASIC1	4.09e-05	2	223	2	18094106
Pubmed	ASIC subunit ratio and differential surface trafficking in the brain.	ASIC2 ASIC1	4.09e-05	2	223	2	26746198
Pubmed	Plasma membrane calcium pump (PMCA) isoform 4 is targeted to the apical membrane by the w-splice insert from PMCA2.	ATP2B2 ATP2B4	4.09e-05	2	223	2	22252018
Pubmed	Localization of chi1-related helicase genes to human chromosome regions 12p11 and 12p13: similarity between parts of these genes and conserved human telomeric-associated DNA.	DDX11 DDX12P	4.09e-05	2	223	2	8833153
Pubmed	Exome sequencing identified rare variants in genes HSPG2 and ATP2B4 in a family segregating developmental dysplasia of the hip.	HSPG2 ATP2B4	4.09e-05	2	223	2	28327142
Pubmed	Plasma membrane Ca²⁺-ATPases can shape the pattern of Ca²⁺ transients induced by store-operated Ca²⁺ entry.	ATP2B2 ATP2B4	4.09e-05	2	223	2	25690014
Pubmed	Changes in H+, K+, and Ca2+ Concentrations, as Observed in Seizures, Induce Action Potential Signaling in Cortical Neurons by a Mechanism That Depends Partially on Acid-Sensing Ion Channels.	ASIC2 ASIC1	4.09e-05	2	223	2	34720879
Pubmed	Protons are a neurotransmitter that regulates synaptic plasticity in the lateral amygdala.	ASIC2 ASIC1	4.09e-05	2	223	2	24889629
Pubmed	Targeted deletion of AP-2alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma.	TFAP2A PAX6	4.09e-05	2	223	2	16186342
Pubmed	The Thumb Domain Mediates Acid-sensing Ion Channel Desensitization.	ASIC2 ASIC1	4.09e-05	2	223	2	27015804
Pubmed	Acid-sensing ion channel 2 (ASIC2) modulates ASIC1 H+-activated currents in hippocampal neurons.	ASIC2 ASIC1	4.09e-05	2	223	2	14960591
Pubmed	TFAP2 transcription factors are regulators of lipid droplet biogenesis.	WNT3A TFAP2A	4.09e-05	2	223	2	30256193
Pubmed	Antibody escape by polyomavirus capsid mutation facilitates neurovirulence.	STAT1 IGHM	4.09e-05	2	223	2	32940605
Pubmed	Genetic analysis indicates that transcription factors AP-2alpha and Pax6 cooperate in the normal patterning and morphogenesis of the lens.	TFAP2A PAX6	4.09e-05	2	223	2	17679940
Pubmed	RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1.	RNF168 STAT1	4.09e-05	2	223	2	30506884
Pubmed	Characterization of acid-sensing ion channels in medium spiny neurons of mouse striatum.	ASIC2 ASIC1	4.09e-05	2	223	2	19376200
Pubmed	Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells.	ADAR DHX9	4.09e-05	2	223	2	38530197
Pubmed	Identification of a receptor for extracellular renalase.	RNLS ATP2B4	4.09e-05	2	223	2	25906147
Pubmed	Altered Expression Pattern of Acid-Sensing Ion Channel Isoforms in Piriform Cortex After Seizures.	ASIC2 ASIC1	4.09e-05	2	223	2	25744567
Pubmed	Characterization of putative human homologues of the yeast chromosome transmission fidelity gene, CHL1.	DDX11 DDX12P	4.09e-05	2	223	2	9013641
Pubmed	Differential regulation of locomotor activity to acute and chronic cocaine administration by acid-sensing ion channel 1a and 2 in adult mice.	ASIC2 ASIC1	4.09e-05	2	223	2	23644053
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	4.09e-05	2	223	2	11672541
Pubmed	Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines.	ATP2B2 ATP2B4	4.09e-05	2	223	2	16216224
Pubmed	Extracellular spermine exacerbates ischemic neuronal injury through sensitization of ASIC1a channels to extracellular acidosis.	ASIC2 ASIC1	4.09e-05	2	223	2	21307247
Pubmed	DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.	ADAR DHX9	4.09e-05	2	223	2	28355180
Pubmed	Central tolerance spares the private high-avidity CD4(+) T-cell repertoire specific for an islet antigen in NOD mice.	PRSS16 PRKDC	4.09e-05	2	223	2	25884569
Pubmed	Bile acid transporters in health and disease.	SLC10A2 ABCB11	4.09e-05	2	223	2	18668439
Pubmed	The serum protein renalase reduces injury in experimental pancreatitis.	RNLS ATP2B4	4.09e-05	2	223	2	29042438
Pubmed	Acid-sensing ion channels (ASICs) are differentially modulated by anions dependent on their subunit composition.	ASIC2 ASIC1	4.09e-05	2	223	2	23135698
Pubmed	Microdiversity of human-plasma-membrane calcium-pump isoform 2 generated by alternative RNA splicing in the N-terminal coding region.	ATP2B2 ATP2B4	4.09e-05	2	223	2	1313367
Pubmed	Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc.	HSPG2 COL6A1	4.09e-05	2	223	2	27377666
Pubmed	Renalase and its receptor, PMCA4b, are expressed in the placenta throughout the human gestation.	RNLS ATP2B4	4.09e-05	2	223	2	35322081
Pubmed	Determinants of ion selectivity in ASIC1a- and ASIC2a-containing acid-sensing ion channels.	ASIC2 ASIC1	4.09e-05	2	223	2	31952079
Pubmed	Serine Phosphorylation of the STAT1 Transactivation Domain Promotes Autoreactive B Cell and Systemic Autoimmunity Development.	STAT1 IGHM	4.09e-05	2	223	2	32253245
Pubmed	The interaction between the first transmembrane domain and the thumb of ASIC1a is critical for its N-glycosylation and trafficking.	ASIC2 ASIC1	4.09e-05	2	223	2	22046405
Pubmed	Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.	PRSS16 PRKDC	4.09e-05	2	223	2	21505262
Pubmed	Effects of elevated Pax6 expression and genetic background on mouse eye development.	TFAP2A PAX6	4.09e-05	2	223	2	19387074
Pubmed	Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion.	DDX11 DDX12P	4.09e-05	2	223	2	32855419
Pubmed	5-HT2CR antagonist/5-HT2CR inverse agonist recovered the increased isolation-induced aggressive behavior of BALB/c mice mediated by ADAR1 (p110) expression and Htr2c RNA editing.	ADAR HTR2C	4.09e-05	2	223	2	29541541
Pubmed	Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion.	ABCA2 ABCB10	4.09e-05	2	223	2	21788586
Pubmed	Specific interaction between RNA helicase A and Tap, two cellular proteins that bind to the constitutive transport element of type D retrovirus.	DHX9 NXF1	4.09e-05	2	223	2	10924507
Pubmed	Acid sensing ion channels in dorsal spinal cord neurons.	ASIC2 ASIC1	4.09e-05	2	223	2	18256271
Pubmed	Colocalization of the rat homolog of the von Hippel Lindau (Vhl) gene and the plasma membrane Ca++ transporting ATPase isoform 2 (Atp2b2) gene to rat chromosome bands 4q41.3-->42.1.	RAF1 ATP2B2	4.09e-05	2	223	2	7587388
Pubmed	Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.	PRSS16 PRKDC	4.09e-05	2	223	2	29061767
Pubmed	The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin MDEG form a heteromultimeric H+-gated Na+ channel with novel properties.	ASIC2 ASIC1	4.09e-05	2	223	2	9360943
Pubmed	Acid-sensing ion channel (ASIC) 1a/2a heteromers have a flexible 2:1/1:2 stoichiometry.	ASIC2 ASIC1	4.09e-05	2	223	2	24847067
Pubmed	The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies.	ASIC1 GPR65	4.09e-05	2	223	2	30194289
Pubmed	Dmrt genes participate in the development of Cajal-Retzius cells derived from the cortical hem in the telencephalon.	RELN WNT3A PAX6	4.13e-05	11	223	3	32012381
Pubmed	Common variants on chromosome 6p22.1 are associated with schizophrenia.	PRSS16 BTN2A2 BTN3A2	4.13e-05	11	223	3	19571809
Pubmed	A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein.	CCNO DHX9 DNMT1 PRKDC	4.52e-05	31	223	4	12171929
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DHX9 DOCK6 DNMT1 DHX57 LTN1 CNTNAP2 DOCK7 PRKDC	5.19e-05	202	223	8	33005030
Pubmed	The DNA sequence and analysis of human chromosome 6.	ERVK-6 PRSS16 BTN3A3 BTN2A2 SERINC1 MED23 DXO ZBTB2 GPR31 BTN3A2 IBTK EYS IGF2R PHF3	5.52e-05	622	223	14	14574404
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	GALK1 USP9X DAB2 GTF3C4 DNMT1 PHF3 ARID2 PRKDC SRRM2 HCFC1	6.25e-05	332	223	10	32786267
Pubmed	Wnt signalling required for expansion of neural crest and CNS progenitors.	WNT3A TFAP2A PAX6	7.09e-05	13	223	3	9353119
Pubmed	FCHo proteins are nucleators of clathrin-mediated endocytosis.	DAB2 ITSN1 TFAP2A	7.09e-05	13	223	3	20448150
Pubmed	Lens induction requires attenuation of ERK signaling by Nf1.	NF1 TFAP2A PAX6	7.09e-05	13	223	3	21233129
Pubmed	Six3 inactivation causes progressive caudalization and aberrant patterning of the mammalian diencephalon.	SSPOP WNT3A SIX6 PAX6	8.25e-05	36	223	4	18094027
Pubmed	Requirements for Jag1-Rbpj mediated Notch signaling during early mouse lens development.	KDR TFAP2A PAX6	8.99e-05	14	223	3	22275127
Pubmed	Altered proliferative ability of neuronal progenitors in PlexinA1 mutant mice.	SEMA6D KDR PAX6	8.99e-05	14	223	3	25975775
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	HK1 USP9X NF1 NXF1 DNMT1 ELP1 DHX57 SPAG9 IGF2R PHF3 DOCK7 PRKDC SRRM2 HCFC1	9.23e-05	653	223	14	22586326
Pubmed	Structure and function of immunoglobulins.	IGLC7 IGHA1 IGHM	1.12e-04	15	223	3	20176268
Pubmed	IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration.	USP9X ELP1 PRKDC	1.12e-04	15	223	3	18303054
Pubmed	STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis.	STAT1 IL23R	1.22e-04	3	223	2	22195034
Pubmed	Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function.	ASIC2 ASIC1	1.22e-04	3	223	2	15987792
Pubmed	Global loss of imprinting leads to widespread tumorigenesis in adult mice.	DNMT1 PRKDC	1.22e-04	3	223	2	16226703
Pubmed	Co-localization of FAM and AF-6, the mammalian homologues of Drosophila faf and canoe, in mouse eye development.	USP9X PAX6	1.22e-04	3	223	2	10704870
Pubmed	Loss of ChlR1 helicase in mouse causes lethality due to the accumulation of aneuploid cells generated by cohesion defects and placental malformation.	DDX11 DDX12P	1.22e-04	3	223	2	17611414
Pubmed	Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.	KDR HSPG2	1.22e-04	3	223	2	23374253
Cytoband	6q12	ADGRB3 EYS PHF3	1.63e-04	22	223	3	6q12
Cytoband	Ensembl 112 genes in cytogenetic band chr6q12	ADGRB3 EYS PHF3	2.71e-04	26	223	3	chr6q12
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN3A3 BTN2A2 BTN3A2	2.46e-04	15	152	3	458
GeneFamily	Acid sensing ion channel subunits	ASIC2 ASIC1	6.91e-04	5	152	2	290
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ABCA13 SSPOP FREM2 USH2A STAB2 FAT3 APOB PKHD1L1 ASXL3 HYDIN OTOG	1.05e-10	184	214	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ABCA13 SSPOP FREM2 USH2A STAB2 FAT3 APOB PKHD1L1 ASXL3 HYDIN OTOG	1.05e-10	184	214	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ABCA13 SSPOP FREM2 USH2A STAB2 FAT3 APOB PKHD1L1 ASXL3 HYDIN OTOG	1.05e-10	184	214	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN ASIC2 RYR1 USH2A HTR2C ENTHD1 THSD7B EYS CNTNAP2 ABCB11 ATP2B2	1.82e-10	150	214	11	0205318a870e091add66ee4305747dda9f51510d
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN ADGRB3 ADGRG4 RYR1 USH2A SLC52A1 THSD7B EYS CNTNAP2	2.53e-08	139	214	9	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	Club_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 CCNO ANKRD36C DDX11 IGLC7 KDR APOB ADAMTS10 MUC4	8.99e-08	161	214	9	bd08a23b415617f6e8748ed2668d578a860ecf91
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 ELAPOR2 ABCA13 FREM2 USH2A FAT3 PKHD1L1 ABCB11 HYDIN	9.48e-08	162	214	9	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN RYR1 USH2A DNAH3 FAT3 THSD7B EYS CNTNAP2	1.05e-06	159	214	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN RYR1 USH2A DNAH3 ENTHD1 THSD7B EYS CNTNAP2	1.27e-06	163	214	8	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	TSHR IGLC7 ALDH1L2 CCL25 PKHD1L1 IGHA1 SLC17A9 IGHM	2.25e-06	176	214	8	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	(05)_Ciliated-(2)_48hpi\|(05)_Ciliated / shred by cell type and Timepoint	ASIC2 ASIC1 NCKAP5 SEMA6B ZBTB32 ABCB11 OTOG	2.35e-06	124	214	7	fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b
ToppCell	COVID-19-kidney-Epithelial_Doublet\|kidney / Disease (COVID-19 only), tissue and cell type	SPATA31A6 RYR1 ENTHD1 EYS IGHA1 IGHM CNTNAP2	2.35e-06	124	214	7	d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CCNO NCKAP5 ZNF608 KDR HTR2C TFAP2A CELSR1 MUC4	3.53e-06	187	214	8	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DAB2 KDR SEMA6B STAB2 PKHD1L1 CELSR1 ATP2B4	4.13e-06	191	214	8	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DAB2 KDR SEMA6B STAB2 PKHD1L1 CELSR1 ATP2B4	4.13e-06	191	214	8	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 NCKAP5 WNT3A ISYNA1 CELSR1 ASXL3 TSLP MUC4	5.59e-06	199	214	8	94a7867e800df352731796de8c24cba133c29622
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast\|COVID-19_Mild / Disease, condition lineage and cell class	TSHR IGLC7 ALDH1L2 CCL25 PKHD1L1 ZBTB32 IGHA1 SLC17A9	5.59e-06	199	214	8	46f31aef26c3da7608082f750d743ad54adbc51a
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN ASIC2 USH2A THSD7B EYS CNTNAP2 ATP2B2	7.56e-06	148	214	7	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDR HSPG2 STAB2 FAT3 ASXL3 MUC4 HYDIN	1.02e-05	155	214	7	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	PND07-Endothelial-Endothelial_lymphatic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN DAB2 KDR WDR17 STAB2 PKHD1L1 CELSR1	1.31e-05	161	214	7	133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN DAB2 KDR WDR17 STAB2 PKHD1L1 CELSR1	1.31e-05	161	214	7	9466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN DAB2 KDR WDR17 STAB2 PKHD1L1 CELSR1	1.31e-05	161	214	7	cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ASPN SLC22A20P FOSB ELP1 RAB11FIP1 SLC17A9 MUC4	1.36e-05	162	214	7	9c9a63adb692651ea5a52cc77b02c5ce11d0ccea
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ASPN SLC22A20P FOSB ELP1 RAB11FIP1 SLC17A9 MUC4	1.36e-05	162	214	7	1d29983b22f963b34e72cfd1eec328d2d7c4932f
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN DAB2 KDR WDR17 STAB2 PKHD1L1 CELSR1	1.36e-05	162	214	7	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	RELN SSPOP CCNJL STAB2 PKHD1L1 ADAMTS12 DAW1	1.42e-05	163	214	7	961c3a1303108afd680365466045f3460a30a7b0
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 USH2A FAT3 PKHD1L1 CNTNAP2 ATP2B2 HYDIN	1.79e-05	169	214	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Bronchial_Brush-Immune-B_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	TMPRSS5 TSHR IGLC7 MED23 IGHA1 SLC17A9 IGHM	1.86e-05	170	214	7	53e9372cb06a2dc5c8ecb3f9af42f3c23da96431
ToppCell	droplet-Kidney-nan-3m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 SSPOP ENTHD1 FSD1 SLC10A2 DAW1 SLC22A2	1.86e-05	170	214	7	dd48fd3c5c67eb71183981f42975a538f12077c3
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN ASIC2 RYR1 ASB5 EYS CNTNAP2 ATP2B2	1.93e-05	171	214	7	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	COVID-19-kidney-Plasma\|kidney / Disease (COVID-19 only), tissue and cell type	CCDC69 TSHR IGLC7 ALDH1L2 BTN3A2 IGHA1 IGHM	1.93e-05	171	214	7	a59a054b8e119215f24dc5c80ad5a8094b3500f9
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	TSHR IGLC7 ALDH1L2 PKHD1L1 IGHA1 SLC17A9 IGHM	2.08e-05	173	214	7	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS16 TSHR ALDH1L2 CCL25 PKHD1L1 ZBTB32 SLC17A9	2.33e-05	176	214	7	dc4e939a07bad21ab36181f9588df3fa662f9a92
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN DAB2 STAB2 PTPN18 PKHD1L1 CELSR1 ATP2B4	2.41e-05	177	214	7	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CCNO ANKRD36C ZNF608 KDR TFAP2A CELSR1 MUC4	2.41e-05	177	214	7	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN DAB2 STAB2 PTPN18 PKHD1L1 CELSR1 ATP2B4	2.41e-05	177	214	7	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CCNO ANKRD36C ZNF608 KDR TFAP2A CELSR1 MUC4	2.41e-05	177	214	7	779ba86f53650772755b52460be03f18bb204e55
ToppCell	ILEUM-inflamed-(9)_Neuro_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN ADGRB3 DDX11 SEMA6D TFAP2A ASXL3 DCHS1	2.50e-05	178	214	7	611504b0a9e6318b18fba83787b03f9245c82252
ToppCell	ILEUM-inflamed-(9)_Enteric_neurons\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN ADGRB3 DDX11 SEMA6D TFAP2A ASXL3 DCHS1	2.50e-05	178	214	7	d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-NK_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS16 MED14 GPR132 IL23R STAB2 RAB11FIP1 CELSR1	2.59e-05	179	214	7	6f657c7a227f860934d0dfec9b97d35fd2cedfd2
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPOCK1 ASIC2 NCKAP5 ASB5 STAB2 FAT3 THSD7B	2.69e-05	180	214	7	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	Control-Myeloid-DC1\|Control / Condition, Lineage and Cell class	NCKAP5 FSIP2 ZNF608 HSPG2 GPR31 ADAMTS10 P2RY6	2.79e-05	181	214	7	5a2a1f017ad23baed9972c68b4a46f4c618ef21a
ToppCell	(6)_Macrophage-(60)_Macrophage\|(6)_Macrophage / shred on Cell_type and subtype	IGLC7 MMP12 SEMA6B IGHA1 IGHM	2.87e-05	74	214	5	356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0
ToppCell	(2)_B_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGLC7 PLEKHF2 PKHD1L1 ZBTB32 IGHA1 IGHM CNTNAP2	2.89e-05	182	214	7	8fe9b3a82159a388ffb642ac4f6aff05b8b5f944
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRSS16 IGLC7 ALDH1L2 CCL25 PKHD1L1 IGHA1 IGHM	3.20e-05	185	214	7	96423bdcf0e85ca41370f79347d27c22f3de98f5
ToppCell	metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGLC7 ALDH1L2 CCL25 PKHD1L1 IGHA1 SLC17A9 IGHM	3.20e-05	185	214	7	bb87fa174f80706fe7be60d3b9fc3e2a6b373038
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLC7 ALDH1L2 FOSB PKHD1L1 IGHA1 SLC17A9 IGHM	3.20e-05	185	214	7	a4792d8df52d80951fb9d022c49821df52100e67
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP32 DAB2 BACE1 AKAP6 SEMA6B COL6A1 ITSN1	3.31e-05	186	214	7	f73cb91e74a806858650ae97f543fc779ba4cff8
ToppCell	Healthy-multiplets\|Healthy / disease group, cell group and cell class	NCKAP5 TSHR IGLC7 CCL25 PKHD1L1 IGHA1 P2RY6	3.31e-05	186	214	7	2ec999b97e95afb898f8083042b0f188d3d234bc
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP32 DAB2 BACE1 AKAP6 SEMA6B COL6A1 ITSN1	3.31e-05	186	214	7	8694ca16c9780729f4fba67ba20e35745f1eb4e9
ToppCell	moderate-Epithelial-Ionocyte\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPOCK1 ASIC2 NCKAP5 ASB5 STAB2 FAT3 THSD7B	3.43e-05	187	214	7	3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ADCY10 PRSS16 PINLYP ENTHD1 PKHD1L1	3.47e-05	77	214	5	a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KDR DOCK6 STAB2 ARHGEF28 CELSR1 ATP2B4	3.55e-05	188	214	7	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KDR DOCK6 STAB2 ARHGEF28 CELSR1 ATP2B4	3.55e-05	188	214	7	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	Int-URO-Lymphocyte-B\|Int-URO / Disease, Lineage and Cell Type	IGLC7 PLEKHF2 PKHD1L1 ZBTB32 IGHA1 IGHM CNTNAP2	3.55e-05	188	214	7	956568df5c4b26089b46673c30dd9a6e9581b0c9
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLC7 ALDH1L2 FOSB PKHD1L1 IGHA1 SLC17A9 IGHM	3.55e-05	188	214	7	fd4d304f1cb41e694d21b5441739eb34a5a13b04
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	73ee4cfb1057832f700be59b6917dedde3e89880
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	c296660061b46e3abae1e7cf29df20274e5a8add
ToppCell	COVID-19_Mild-Lymphoid_P-Plasmablast\|COVID-19_Mild / Disease group, lineage and cell class	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	254f058850b41a5974a380f3710db7c01a51fb6b
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	f2daf4889ef98bbefe3e44832618ac102a75b4d9
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK6 CCNJL RAB11FIP1 PKHD1L1 IGF2R SLC22A2 ATP2B4	3.67e-05	189	214	7	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TSHR IGLC7 ALDH1L2 CCL25 PKHD1L1 IGHA1 SLC17A9	3.67e-05	189	214	7	a1bda6ed5c52a5d33d229018cb5982cae6305533
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	31594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCell	COVID-19_Mild-Lymphoid_P\|COVID-19_Mild / Disease group, lineage and cell class	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	0b3d3bd697e79decae7e21c513fab9da3b2a47c5
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	3.67e-05	189	214	7	9de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFT140 RNF168 SLC25A38 PKHD1L1 ABCB10 FIGNL1 ATP2B4	3.67e-05	189	214	7	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHR IGLC7 PKHD1L1 ZBTB32 IGHA1 SLC17A9 IGHM	3.79e-05	190	214	7	7de42d8572599693618fb920798a2e52a0b5265c
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN DAB2 KDR SEMA6B STAB2 PKHD1L1 CELSR1	3.79e-05	190	214	7	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CCNO ZNF608 KDR HTR2C CELSR1 P2RY6 MUC4	3.79e-05	190	214	7	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN DAB2 KDR SEMA6B STAB2 PKHD1L1 CELSR1	3.79e-05	190	214	7	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN DAB2 KDR SEMA6B STAB2 PKHD1L1 CELSR1	3.79e-05	190	214	7	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	ILEUM-non-inflamed-(8)_Activated_fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	BACE1 SLC49A3 COL6A1 PINLYP ADAMTS12 ADAMTS10 TSLP	3.79e-05	190	214	7	39fa110d19c97c7cac99f5fb91b26bc08e2f3b42
ToppCell	COVID-19_Severe-Plasmablast\|World / disease group, cell group and cell class	TSHR IGLC7 ALDH1L2 PKHD1L1 ZBTB32 IGHA1 SLC17A9	4.06e-05	192	214	7	a333053fe2bd206c32790916bfc5fce904ab7f57
ToppCell	ASK452-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	BBS4 ZNF595 ADCY7 PTPN4 GPR65 DUS4L BTN3A2	4.06e-05	192	214	7	f04ee5aaa54c39b7493098fb3d2f78168d6b8060
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCA13 ZNF608 AKAP6 CFAP47 DNAH3 CELSR1 HYDIN	4.19e-05	193	214	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF608 PLEKHF2 PKHD1L1 ZBTB32 IGHA1 SLC17A9 IGHM	4.19e-05	193	214	7	89831e1007944e47719e58f23bfef5f1944cae23
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	CCNO ANKRD36C DDX11 ZNF608 KDR TFAP2A MUC4	4.19e-05	193	214	7	9d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MORN1 ABCA13 AKAP6 CFAP47 DNAH3 MUC4 HYDIN	4.33e-05	194	214	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	ADAR STAT1 DDX60L NFKBIZ SPAG9 IGHA1 IGHM	4.33e-05	194	214	7	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGLC7 CCL25 PKHD1L1 ZBTB32 IGHA1 SLC17A9 IGHM	4.33e-05	194	214	7	c531c1759a3dfbc85d00ed5eaba35cd14b1b2ac1
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TSHR IGLC7 CCL25 PKHD1L1 IGHA1 SLC17A9 IGHM	4.47e-05	195	214	7	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 ADGRB3 ARHGEF28 FAT3 NFKBIZ THSD7B ASXL3	4.47e-05	195	214	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Epithelial_cells-Club_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	CCNO ANKRD36C DDX11 KDR TFAP2A P2RY6 MUC4	4.47e-05	195	214	7	b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 ADGRB3 ARHGEF28 FAT3 NFKBIZ THSD7B ASXL3	4.47e-05	195	214	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BTN2A2 GPR65 FOSB ENTHD1 NFKBIZ ZBTB32 IGHA1	4.62e-05	196	214	7	4f007bff8ed7592c277d8397b054e1c799157912
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC69 RELN ADGRB3 KDR SEMA6B HSPG2 HYAL1	4.62e-05	196	214	7	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BTN2A2 GPR65 FOSB ENTHD1 NFKBIZ ZBTB32 IGHA1	4.62e-05	196	214	7	55e562be096a510f6414811238e633accd18570e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC69 RELN ADGRB3 KDR SEMA6B HSPG2 HYAL1	4.62e-05	196	214	7	473980c827443464d08a0be28c53e3536369b12a
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BTN2A2 GPR65 FOSB ENTHD1 NFKBIZ ZBTB32 IGHA1	4.62e-05	196	214	7	102bced15ba1f2f9aafdcf07e64195b8e1b0d87c
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BTN2A2 GPR65 FOSB ENTHD1 NFKBIZ ZBTB32 IGHA1	4.62e-05	196	214	7	57fd7b39611e30a68429dea1801476b0d44c6dc1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC69 RELN ADGRB3 KDR SEMA6B HSPG2 HYAL1	4.62e-05	196	214	7	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TSHR IGLC7 CCL25 PKHD1L1 IGHA1 SLC17A9 IGHM	4.62e-05	196	214	7	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ASIC2 FSIP2 ASB5 ZNF589 STAB2 FAT3 CNTNAP2	4.77e-05	197	214	7	f7ef62d78336812573148f8bfce401877ec4e29c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ABCA2 PTPN4 BTN3A3 SPG11 BTN3A2 SRRM2 ATP2B4	4.77e-05	197	214	7	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ADAR STAT1 DDX60L NFKBIZ SPAG9 PHF3 SRRM2	4.77e-05	197	214	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	mild-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PDE4A DAB2 ADCY7 PTPN4 PTPN18 IGF2R SIGLEC7	4.93e-05	198	214	7	1d20fc9948965de52a98f758035edfdd12cafc5f
ToppCell	(1)_T_cell-(13)_Th17\|(1)_T_cell / shred on Cell_type and subtype	PDE4A IL23R GPR65 FOSB NFKBIZ FSD1 IGHA1	4.93e-05	198	214	7	a3ac65295da7baed447786a302b01db1cc824db2
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CCNO NCKAP5 ZNF608 KDR CELSR1 P2RY6 MUC4	4.93e-05	198	214	7	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADAR STAT1 DDX60L NFKBIZ SPAG9 PHF3 SRRM2	4.93e-05	198	214	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADAR STAT1 DDX60L NFKBIZ SPAG9 PHF3 SRRM2	4.93e-05	198	214	7	28ef3fc4c17dcb765537b75917f7db78baa522db
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A	MORN1 HLCS BBS4 ATP9B STX12 BTN2A2 TECPR2 ZMIZ2 PCBP4 DOCK6 GPR132 HSPG2 NPEPL1 ARR3 P2RY6	6.26e-10	199	212	15	2153_UP
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A	BTN3A3 BTN2A2 ZNF589 CCNJL FSD1 PTPN18 TFAP2A BTN3A2 PHF3 CNTNAP2 RAPGEFL1	2.42e-06	196	212	11	4204_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; HL60; HT_HG-U133A	PDE4A MORN1 DAB2 STX12 ZMIZ2 DOCK6 STAB2 FOSB TFAP2A ARR3 RAPGEFL1	2.67e-06	198	212	11	2158_UP
Drug	2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A	RNLS ASIC1 DAB2 CCNO BACE1 BTN2A2 ZMIZ2 COL6A1 ITSN1 TFAP2A	1.23e-05	190	212	10	6199_UP
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	ABCA2 STAT1 FZR1 NF1 COL6A1 SPAG9 PTPN18 TFAP2A P2RY6 SCARB2	1.34e-05	192	212	10	4342_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; PC3; HT_HG-U133A	IFT140 FZR1 BTN2A2 ZNF589 COL6A1 ISYNA1 PTPN18 TFAP2A BTN3A2 CNTNAP2	1.54e-05	195	212	10	4198_DN
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HT_HG-U133A	IFT140 HLCS NF1 ZMIZ2 DOCK6 DNAH3 BTN3A2 ORC4 PHF3 HCFC1	1.61e-05	196	212	10	4656_DN
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	HLCS NF1 SEMA6D ZNF589 SLC52A1 ARHGEF28 PHF3 CNTNAP2 PAX6 ATP2B2	1.68e-05	197	212	10	3361_UP
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	ASIC1 CCNO HLCS STAT1 FZR1 NF1 ZMIZ2 MRPS18C NPEPL1 TIGD6	1.76e-05	198	212	10	3754_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	IFT140 PDE4A FZR1 TECPR2 ZNF589 HSPG2 NPEPL1 PTPN18 TIGD6 RAPGEFL1	1.76e-05	198	212	10	6742_DN
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A	MED14 PEX7 NF1 COL6A1 ISYNA1 FPGS DUS4L FSD1 NPEPL1 BTN3A2	1.83e-05	199	212	10	7311_DN
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	HLCS RYR1 FZR1 ZMIZ2 DOCK6 HSPG2 SLC52A1 MRPS18C SIGLEC7 HCFC1	1.83e-05	199	212	10	6841_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	PDE4A FZR1 BTN3A3 TECPR2 ZMIZ2 COL6A1 BTN3A2 TIGD6 SLC10A2 CNTNAP2	1.83e-05	199	212	10	3741_DN
Drug	butenafine	STAT1 SLC22A2 TSLP	4.31e-05	8	212	3	ctd:C067594
Drug	Zinc Sulfate	ELAPOR2 IFT140 PDE4A HK1 CCNO STAT1 DDX11 FZR1 SERINC1 KDR IL23R SEMA6B FOSB MRPS18C THSD7B PKHD1L1 IGHM ABCB11 LY75	6.69e-05	739	212	19	ctd:D019287
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	IFT140 MED14 FZR1 ISYNA1 PTPN18 TFAP2A TIGD6 HCFC1 RAPGEFL1	8.59e-05	193	212	9	4186_DN
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ASIC1 MED14 CCNO PEX7 FZR1 NF1 HSPG2 ITGA10 ATP2B4	8.59e-05	193	212	9	7187_UP
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A	GALK1 MORN1 HLCS ATP9B NF1 ZNF589 PCBP4 MRPS18C CNTNAP2	8.59e-05	193	212	9	5922_UP
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A	GALK1 ASIC1 HLCS FZR1 NF1 ZNF589 COL6A1 TIGD6 PHF3	8.93e-05	194	212	9	5762_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ABCA2 PDE4A USP9X HLCS BBS4 BTN2A2 HSPG2 ATP2B4 HCFC1	8.93e-05	194	212	9	3861_DN
Drug	Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	ASIC1 MED14 BTN3A3 NF1 COL6A1 TFAP2A SCARB2 CNTNAP2 RAPGEFL1	8.93e-05	194	212	9	6763_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	IFT140 ARHGAP32 BTN3A3 DOCK6 COL6A1 ITGA10 MRPS18C TFAP2A RAPGEFL1	9.29e-05	195	212	9	4199_DN
Drug	adenine	HK1 RNLS SPOCK1 CCNO ADAR ADCY7 STAT1 RYR1 PTPN4 MED23 DNMT1 CARM1 FPGS IGF2R P2RY6	9.34e-05	510	212	15	CID000000190
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ASIC1 HLCS TECPR2 ZNF589 SEMA6B COL6A1 STAB2 ARHGEF28 ATP2B2	9.66e-05	196	212	9	4421_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	CCNO FZR1 BTN2A2 DOCK6 FSD1 NPEPL1 PTPN18 TFAP2A HCFC1	9.66e-05	196	212	9	7377_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A	PEX7 BBS4 ADCY7 BTN3A3 ITSN1 NPEPL1 PTPN18 PHF3 SRRM2	9.66e-05	196	212	9	6335_DN
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ADGRB3 FZR1 ZMIZ2 ZNF589 SLC52A1 TFAP2A SIGLEC7 MUC4 ATP2B2	1.00e-04	197	212	9	6054_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	IFT140 ASIC1 NF1 ZMIZ2 ZNF589 DOCK6 PHF3 SRRM2 HCFC1	1.00e-04	197	212	9	2326_DN
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	CCNO STAT1 FZR1 ZNF589 HSPG2 DNAH3 ITSN1 ELP1 NPEPL1	1.00e-04	197	212	9	2796_DN
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	PRSS16 HLCS TECPR2 ZMIZ2 ZNF589 PCBP4 CCNJL P2RY6 CNTNAP2	1.00e-04	197	212	9	6428_DN
Drug	Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	IFT140 PRSS16 ASIC1 MED14 CCNO HLCS FZR1 NF1 ITGA10	1.00e-04	197	212	9	7180_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	ABCA2 CCNO HLCS FZR1 HSPG2 COL6A1 PTPN18 TFAP2A HCFC1	1.00e-04	197	212	9	4336_DN
Drug	Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; HL60; HT_HG-U133A	MORN1 SPOCK1 DAB2 STAT1 FZR1 ZMIZ2 TFAP2A ARR3 P2RY6	1.00e-04	197	212	9	2427_UP
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ABCA2 GALK1 ASPN ATP9B NF1 COL6A1 PHF3 CNTNAP2 HCFC1	1.04e-04	198	212	9	6473_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ABCA2 ASIC1 FZR1 BTN2A2 NF1 ZMIZ2 TIGD6 ARR3 HCFC1	1.04e-04	198	212	9	1541_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA	ABCA2 MED14 HLCS ATP9B STAT1 TECPR2 ZMIZ2 ZNF589 DUS4L	1.04e-04	198	212	9	1020_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	HLCS ATP9B FZR1 NF1 ZMIZ2 ZNF589 COL6A1 PHF3 HCFC1	1.04e-04	198	212	9	4704_DN
Drug	Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A	IFT140 HLCS TSHR NF1 SEMA6D KDR DOCK6 HSPG2 COL6A1	1.04e-04	198	212	9	3107_UP
Drug	Harpagoside [19210-12-9]; Up 200; 8uM; MCF7; HT_HG-U133A	ASIC1 CCNO FZR1 NF1 ZNF589 COL6A1 ADAMTS12 P2RY6 SRRM2	1.04e-04	198	212	9	4981_UP
Drug	nifedipine; Down 200; 10uM; MCF7; HG-U133A	RELN PRSS16 MED14 COL6A1 DNAH3 SIGLEC7 SLC17A9 DCHS1 RAPGEFL1	1.08e-04	199	212	9	603_DN
Drug	DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A	ABCA2 MORN1 HLCS FZR1 BTN3A3 DUS4L PTPN18 BTN3A2 CNTNAP2	1.08e-04	199	212	9	7518_DN
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	BBS4 PTPN4 NF1 FOSB ELP1 NPEPL1 TFAP2A TIGD6 SIGLEC7	1.08e-04	199	212	9	3128_DN
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; HL60; HT_HG-U133A	MORN1 ZMIZ2 GPR132 HSPG2 NPEPL1 ADAMTS12 ARR3 CNTNAP2 ATP2B4	1.08e-04	199	212	9	2139_UP
Drug	Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A	ASPN HLCS NF1 ZMIZ2 DOCK6 TIGD6 SIGLEC7 SRRM2 RAPGEFL1	1.13e-04	200	212	9	6246_UP
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ABCA2 FZR1 ZMIZ2 SLC52A1 MRPS18C ORC4 PHF3 SRRM2 HCFC1	1.13e-04	200	212	9	3276_DN
Disease	linoleic acid measurement	SNX17 DOCK6 APOB THSD7B IGF2R ZNF335 SLC22A2 DOCK7 ABCB11	7.44e-06	186	208	9	EFO_0006807
Disease	phospholipids in medium VLDL measurement	SNX17 APOB IGF2R SLC22A2 DOCK7	3.29e-05	52	208	5	EFO_0022154
Disease	cholesterol in small VLDL measurement	SNX17 APOB IGF2R SLC22A2 DOCK7	3.62e-05	53	208	5	EFO_0022228
Disease	Massive Hepatic Necrosis	PANX1 PRKDC	4.95e-05	2	208	2	C0001364
Disease	apolipoprotein B measurement	GALK1 HK1 SNX17 BACE1 NF1 DOCK6 CARM1 RAF1 PINLYP APOB IGF2R SLC22A2 DOCK7 ABCB11 HYDIN	7.99e-05	663	208	15	EFO_0004615
Disease	omega-6 polyunsaturated fatty acid measurement	DOCK6 IL23R APOB IGF2R ZNF335 SLC22A2 DOCK7 ABCB11	8.32e-05	197	208	8	EFO_0005680
Disease	Disorder of eye	PEX7 BBS4 GPR179 FREM2 CC2D2A USH2A EYS PAX6	1.38e-04	212	208	8	C0015397
Disease	Warsaw breakage syndrome (implicated_via_orthology)	DDX11 DDX12P	1.48e-04	3	208	2	DOID:0060535 (implicated_via_orthology)
Disease	Polydactyly	IFT140 USP9X BBS4 FREM2 CC2D2A TFAP2A	1.86e-04	117	208	6	C0152427
Disease	omega-3 polyunsaturated fatty acid measurement	SNX17 ZMIZ2 DOCK6 APOB SLC22A2 DOCK7	1.95e-04	118	208	6	EFO_0010119
Disease	IGF-1 measurement	IFT140 PDE4A SNX17 ZMIZ2 DDX60L DOCK6 DNMT1 DOP1B STAB2 ELP1 IGF2R SLC22A2	1.95e-04	488	208	12	EFO_0004627
Disease	retinitis pigmentosa (is_implicated_in)	IFT140 HK1 CC2D2A USH2A	1.98e-04	41	208	4	DOID:10584 (is_implicated_in)
Disease	glycoprotein measurement	PRSS16 SNX17 APOB SLC22A2 DOCK7 HYDIN	2.04e-04	119	208	6	EFO_0004555
Disease	triglycerides in large LDL measurement	APOB IGF2R SLC22A2 DOCK7	2.39e-04	43	208	4	EFO_0022319
Disease	free cholesterol in medium VLDL measurement	SNX17 APOB SLC22A2 DOCK7	3.37e-04	47	208	4	EFO_0022269
Disease	Intellectual Disability	HK1 TMEM94 NF1 MED23 WASF1 AKAP6 RTTN AGO1 ZNF335 PAX6 EIF3F	3.58e-04	447	208	11	C3714756
Disease	apolipoprotein A 1 measurement	RNF168 BACE1 TSHR ADAR FZR1 BTN3A3 ZMIZ2 MED23 DOCK6 ARHGEF28 ITGA10 SPG11 APOB SLC10A2 DOCK7 ABCB11	3.64e-04	848	208	16	EFO_0004614
Disease	total lipids in lipoprotein particles measurement	DOCK6 APOB SLC22A2 DOCK7	3.66e-04	48	208	4	EFO_0022309
Disease	total blood protein measurement	GALK1 RNF168 RNLS DAB2 TMPRSS5 CC2D2B DNAH3 NPEPL1 NSUN7 SLC22A2 HYDIN	3.72e-04	449	208	11	EFO_0004536
Disease	cholesterol in medium LDL measurement	SNX17 APOB IGF2R DOCK7	3.96e-04	49	208	4	EFO_0022224
Disease	Anophthalmia-microphthalmia syndrome	TFAP2A SIX6 PAX6	4.18e-04	21	208	3	cv:C5680330
Disease	factor VIII measurement, coagulation factor measurement	ASIC2 STAB2	4.88e-04	5	208	2	EFO_0004630, EFO_0004634
Disease	total lipids in medium LDL	SNX17 APOB IGF2R DOCK7	4.98e-04	52	208	4	EFO_0022180
Disease	phosphatidylinositol measurement	SLCO1B3 DOCK6 APOB SCARB2 DOCK7	5.75e-04	95	208	5	EFO_0010230
Disease	total lipids in medium VLDL	APOB IGF2R SLC22A2 DOCK7	5.76e-04	54	208	4	EFO_0022153
Disease	body weight	RELN SPOCK1 DAB2 ADGRB3 BTN2A2 SEMA6D ZMIZ2 ZNF589 AKAP6 RTTN THSD7B BTN3A2 ADAMTS10 TNNI3K EYS ZNF341 PHF3 ASXL3 ATP2B4 RAPGEFL1	6.41e-04	1261	208	20	EFO_0004338
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B2 ATP2B4	7.28e-04	6	208	2	DOID:0050429 (implicated_via_orthology)
Disease	triglycerides in IDL measurement	APOB IGF2R SLC22A2 DOCK7	7.56e-04	58	208	4	EFO_0022149
Disease	intestinal permeability measurement	ASIC2 COL6A1 STAB2	7.96e-04	26	208	3	EFO_0011031
Disease	phospholipids in VLDL measurement	APOB IGF2R SLC22A2 DOCK7	8.06e-04	59	208	4	EFO_0022301
Disease	phospholipids in small VLDL measurement	SNX17 APOB SLC22A2 DOCK7	8.59e-04	60	208	4	EFO_0022146
Disease	free cholesterol in VLDL measurement	APOB IGF2R SLC22A2 DOCK7	9.14e-04	61	208	4	EFO_0022276
Disease	acisoga measurement	SLC52A1 IGF2R	1.01e-03	7	208	2	EFO_0800068
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SPG11 APOB BTN3A2 IGF2R ZNF335 SLC22A2 DOCK7	1.05e-03	222	208	7	EFO_0008317, EFO_0020943
Disease	cholesterol in large VLDL measurement	APOB IGF2R SLC22A2 DOCK7	1.16e-03	65	208	4	EFO_0021902
Disease	total lipids in small VLDL	APOB IGF2R SLC22A2 DOCK7	1.30e-03	67	208	4	EFO_0022148
Disease	progressive supranuclear palsy	HK1 ATP2B2 ATP2B4	1.34e-03	31	208	3	MONDO_0019037
Disease	cholesteryl esters to total lipids in large LDL percentage	APOB SLC22A2 DOCK7	1.34e-03	31	208	3	EFO_0022249
Disease	common bile duct neoplasm (is_marker_for)	APOB MUC4	1.35e-03	8	208	2	DOID:4608 (is_marker_for)
Disease	triglycerides in very small VLDL measurement	APOB IGF2R SLC22A2 DOCK7	1.37e-03	68	208	4	EFO_0022144
Disease	Colorectal Carcinoma	ABCA13 SLCO1B3 NF1 KDR AKAP6 DNAH3 FPGS APOB TNNI3K SIGLEC7 ABCB10 DCHS1 ABCB11	1.52e-03	702	208	13	C0009402
Disease	Schizophrenia	ARHGAP32 RELN PDE4A HK1 PRSS16 ABCA13 BACE1 ADCY7 KDR DNMT1 HTR2C ADAMTS12 CNTNAP2 ERVK-8 PAX6	1.58e-03	883	208	15	C0036341
Disease	clopidogrel metabolite measurement	ASIC2 ATP2B2 ATP2B4	1.61e-03	33	208	3	EFO_0007966
Disease	mitral valve prolapse (is_implicated_in)	TSHR DCHS1	1.72e-03	9	208	2	DOID:988 (is_implicated_in)
Disease	behavioural disinhibition measurement	ADGRB3 KPNA7 SEMA6D ENTHD1	1.97e-03	75	208	4	EFO_0006946
Disease	docosahexaenoic acid measurement	SNX17 ZMIZ2 DOCK6 APOB DOCK7	2.10e-03	127	208	5	EFO_0007761
Disease	Graves ophthalmopathy (is_implicated_in)	TSHR IL23R	2.14e-03	10	208	2	DOID:0081120 (is_implicated_in)
Disease	level of Triacylglycerol (51:3) in blood serum	SNX17 APOB	2.14e-03	10	208	2	OBA_2045163
Disease	age at onset, multiple sclerosis	RELN NCKAP5	2.14e-03	10	208	2	EFO_0004847, MONDO_0005301
Disease	mean corpuscular hemoglobin concentration	IFT140 HK1 MORN1 ALDH8A1 TSHR FZR1 CC2D2A SLC22A20P ITSN1 RTTN ENTHD1 C16orf96 ABCB11 PRKDC EIF3F LY75 ATP2B4	2.24e-03	1105	208	17	EFO_0004528
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB IGF2R DOCK7	2.25e-03	37	208	3	EFO_0022252
Disease	autism spectrum disorder, schizophrenia	PRSS16 TMPRSS5 BTN2A2 SLC52A1 ENTHD1 BTN3A2 ATP2B2 ATP2B4	2.34e-03	327	208	8	EFO_0003756, MONDO_0005090
Disease	cholesteryl ester measurement	SNX17 DOCK6 APOB EYS IGF2R SLC22A2 DOCK7	2.41e-03	257	208	7	EFO_0010351
Disease	polyunsaturated fatty acid measurement	DOCK6 APOB SLC22A2 DOCK7 ABCB11	2.41e-03	131	208	5	EFO_0010733
Disease	sleep disorder (implicated_via_orthology)	NF1 TFAP2A	2.61e-03	11	208	2	DOID:535 (implicated_via_orthology)
Disease	pericalcarine cortex volume measurement	SEMA6D ABCB10	2.61e-03	11	208	2	EFO_0010322
Disease	Graves' disease (is_implicated_in)	TSHR IL23R DNMT1	2.62e-03	39	208	3	DOID:12361 (is_implicated_in)
Disease	Autistic Disorder	RELN PDE4A ASIC2 NF1 AGO1 CNTNAP2 PAX6	2.62e-03	261	208	7	C0004352
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	SPG11 APOB BTN3A2 IGF2R ZNF335 SLC22A2 DOCK7	2.79e-03	264	208	7	EFO_0008317, EFO_0020944
Disease	ciliopathy (implicated_via_orthology)	BBS4 CC2D2B CC2D2A	2.81e-03	40	208	3	DOID:0060340 (implicated_via_orthology)
Disease	Congenital small ears	FREM2 TFAP2A ORC4	3.02e-03	41	208	3	C0152423
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	SPG11 APOB BTN3A2 ASXL3 SLC22A2 DOCK7	3.04e-03	200	208	6	EFO_0004611, EFO_0020945
Disease	lipoprotein measurement, phospholipid measurement	DOCK6 APOB DOCK7 ABCB11	3.11e-03	85	208	4	EFO_0004639, EFO_0004732
Disease	sialic acid-binding Ig-like lectin 14 measurement	ARHGEF28 SIGLEC14	3.12e-03	12	208	2	EFO_0008284
Disease	Congenital muscular dystrophy	RYR1 COL6A1	3.12e-03	12	208	2	cv:C0699743
Disease	autistic disorder (is_implicated_in)	RELN NF1 CNTNAP2	3.24e-03	42	208	3	DOID:12849 (is_implicated_in)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	SNX17 DOCK6 APOB IGF2R SLC22A2 CNTNAP2 DOCK7	3.43e-03	274	208	7	EFO_0004530, EFO_0004612
Disease	liver cirrhosis (is_implicated_in)	ADAR SPAG9 ABCB11	3.46e-03	43	208	3	DOID:5082 (is_implicated_in)
Disease	putamen volume change measurement	CNTNAP2 DCHS1	3.66e-03	13	208	2	EFO_0021495
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK6 DOCK7	3.66e-03	13	208	2	OBA_2045159
Disease	colon carcinoma (is_marker_for)	SLCO1B3 IGF2R	3.66e-03	13	208	2	DOID:1520 (is_marker_for)
Disease	total lipids in very small VLDL measurement	SNX17 APOB DOCK7	3.94e-03	45	208	3	EFO_0022156
Disease	Malignant neoplasm of breast	MED14 HLCS ADAR STAT1 STX12 NF1 KDR DNMT1 AKAP6 RAF1 ELP1 TRAPPC8 TFAP2A BTN3A2 ABCB10 DAW1	4.09e-03	1074	208	16	C0006142
Disease	carbohydrate measurement	EYS ATP2B2 ATP2B4	4.19e-03	46	208	3	EFO_0004998
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	SPG11 APOB BTN3A2 SLC22A2 DOCK7	4.30e-03	150	208	5	EFO_0004611, EFO_0020947
Disease	total lipids in small LDL	SNX17 APOB SLC22A2	4.46e-03	47	208	3	EFO_0022168
Disease	free cholesterol in small VLDL measurement	SNX17 APOB DOCK7	4.46e-03	47	208	3	EFO_0022272
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DOCK6 APOB SLC22A2 DOCK7 ABCB11	4.68e-03	153	208	5	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	DOCK6 APOB IGF2R SLC22A2 DOCK7	4.68e-03	153	208	5	EFO_0004611, EFO_0020944
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DOCK6 SPG11 APOB BTN3A2 IGF2R SLC22A2 DOCK7	4.75e-03	291	208	7	EFO_0008317, EFO_0020946
Disease	triacylglycerol 52:3 measurement	SNX17 APOB	4.89e-03	15	208	2	EFO_0010415
Disease	RASopathy	NF1 RAF1	4.89e-03	15	208	2	cv:C5555857
Disease	economic and social preference	AKAP6 LRRC58 ATP2B2 ATP2B4	4.99e-03	97	208	4	EFO_0004827
Disease	cholesterol in small LDL measurement	SNX17 APOB IGF2R	5.01e-03	49	208	3	EFO_0022227
Disease	polyunsaturated fatty acids to total fatty acids percentage	APOB ZNF335 DOCK7	5.30e-03	50	208	3	EFO_0022303
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	SNX17 APOB DOCK7 ABCB11	5.36e-03	99	208	4	EFO_0004611, EFO_0007878
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SPG11 APOB BTN3A2 IGF2R ZNF335 SLC22A2	5.38e-03	225	208	6	EFO_0008317, EFO_0020947
Disease	Spondyloepiphyseal Dysplasia	KDR HSPG2	5.56e-03	16	208	2	C0038015
Disease	Schwartz-Jampel Syndrome	KDR HSPG2	5.56e-03	16	208	2	C0036391
Disease	Inherited oocyte maturation defect	PANX1 KPNA7	5.56e-03	16	208	2	cv:CN238505
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	KDR HSPG2	5.56e-03	16	208	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	KDR HSPG2	5.56e-03	16	208	2	C4551479
Disease	Seasonal Affective Disorder	PDE4A HTR2C	5.56e-03	16	208	2	C0085159
Disease	Melnick-Needles Syndrome	KDR HSPG2	5.56e-03	16	208	2	C0025237
Disease	phospholipids in very small VLDL measurement	SNX17 APOB DOCK7	5.61e-03	51	208	3	EFO_0022300
Disease	phospholipids:total lipids ratio	DOCK6 APOB IGF2R ZNF335 SLC22A2 DOCK7	5.61e-03	227	208	6	EFO_0020946
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	SNX17 APOB DOCK7 ABCB11	5.95e-03	102	208	4	EFO_0004329, EFO_0004611
Disease	Van Buchem disease	KDR HSPG2	6.27e-03	17	208	2	C0432272
Disease	squamous cell lung carcinoma	PANX1 ADAR BTN3A3 TFAP2A BTN3A2	6.41e-03	165	208	5	EFO_0000708
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	APOB IGF2R SLC22A2 DOCK7 ABCB11	6.57e-03	166	208	5	EFO_0004530, EFO_0004611

Protein segments in the cluster

Peptide	Gene	Start	Entry
AQEQEPLQTGLFCIT	PTPN18	146	Q99952
VCFVPALTSRSQGQS	CEP295NL	286	Q96MC4
CGAGFPLNQSEVLAS	BACE1	216	P56817
SLELFQTCAVLSPQS	BBS4	86	Q96RK4
LCNGATSVLFESTPV	ACSS1	351	Q9NUB1
CIPATVRSSFANQGE	ALDH8A1	271	Q9H2A2
IQEVSGSCNLPAAIF	CCL25	51	O15444
VQLLTPCSAQFSVLG	BTN3A3	21	O00478
TTTPVAADCFQLLGV	CCNO	166	P22674
NPGSTVFTEDCNILL	DNMT1	1181	P26358
VDIISTLACIQPNFS	ADGRG4	786	Q8IZF6
DLAFNQCPLNATGTT	ADGRB3	531	O60242
NTGARVITSILCNPA	GOT1L1	291	Q8NHS2
RSVGAELNVLPFCTQ	ALDH1L2	96	Q3SY69
TCPGLLISEAAQNST	GPR31	146	O00270
TCVLNDPNFVLIGSF	HTR2C	206	P28335
TFPLQLESGQTVECT	AGO1	291	Q9UL18
TNQCSLISNGPSLEL	ARID2	1316	Q68CP9
TTLAQFQTPVQDLCL	CCNJL	341	Q8IV13
FGSPAVCAAVTALQN	TFAP2A	386	P05549
GVIPFVQSLLCNTGS	ABCA13	66	Q86UQ4
GTVSQEPILFSCSIA	ABCB10	571	Q9NRK6
LNLGNASPCLEAFAT	ABCB11	371	O95342
GINQTENPFLCTVVA	CELSR1	2521	Q9NYQ6
CVALIIIAFSQGDPS	ADCY7	46	P51828
LENLVAQNTTGPVFC	ADCY10	1496	Q96PN6
FCGQGIVPETFTLSN	DHTKD1	336	Q96HY7
GCIVFPFSALLQQSE	CC2D2B	1001	Q6DHV5
SNSIARVGVNDFCPT	ASPN	321	Q9BXN1
SQSFAVTPILAASCQ	ARR3	266	P36575
IVAFTGACITQDSPL	ATP2B2	891	Q01814
IVAFTGACITQDSPL	ATP2B4	856	P23634
SGCRLSSVEANNPLV	ASXL3	1736	Q9C0F0
NRCITNSIPAAEGTL	ADAMTS10	506	Q9H324
CNINEDSGLPLAFTI	ADAMTS12	376	P58397
AQSLVFPAVTLCNLN	ASIC2	81	Q16515
PLNGDTAITVQLCAS	CCDC69	36	A6NI79
VFDGSSCISPTIVQQ	RAF1	21	P04049
TVQPGQLAEFRCSAT	HSPG2	1876	P98160
LCDPNLSFDAVTTVG	MMP12	281	P39900
CPSNTAALLASFAVQ	PTPN4	141	P29074
EGCAFLNGSPQNTLV	ISYNA1	271	Q9NPH2
VQPGNILDSFTVCNS	SPAG9	776	O60271
FSCNLSEASPEVLGV	LTN1	1206	O94822
CRNFPGSSQSEIIQA	ARHGEF28	1361	Q8N1W1
SGTVLPAVEQCLNRS	ANKRD36C	366	Q5JPF3
NQETLIQTPFGFECI	MORN1	281	Q5T089
LLSEGVCTNDNIPSV	PAX6	106	P26367
QSAQTPIAVIGLTCR	ORC4	181	O43929
RENPFLTNGITSCSL	DAB2	251	P98082
VDQFIPLSCSGFQST	ENTHD1	521	Q8IYW4
NCLNELAGTVPSTVA	HCFC1	1731	P51610
CFLAGNNFSPTVNLE	MUC4	5156	Q99102
TSSQEFLVPNDLIGC	PCBP4	241	P57723
TQPGTCFLQVTATDA	DCHS1	591	Q96JQ0
IGLNVFLSNQSCFPA	FIGNL1	236	Q6PIW4
IKGVNSSDPVLCFQA	KPNA7	76	A9QM74
ESQFCPNQSLVSLLG	NFKBIZ	331	Q9BYH8
LCTDAINITQPRFSG	EYS	2406	Q5T1H1
DLNSTQCVPLESQGF	GPR179	296	Q6PRD1
GCNFAILQSDPKTSL	IBTK	521	Q9P2D0
FQVTTGLQVPSAVRC	FSD1	466	Q9BTV5
VSCTQQLPALGDLFS	ATP9B	281	O43861
ETEQLCATLFQLPGA	DOP1B	771	Q9Y3R5
TVNDLGICLPITNTA	KIAA1109	3336	Q2LD37
CTDQPGVSITSFTQL	FREM2	1471	Q5SZK8
ILIGCGFNVTNSNPT	HLCS	596	P50747
SPFVCLSGNTDNDLL	DDX60L	1571	Q5H9U9
TLGCNSVLIQFATPN	CARM1	101	Q86X55
ENIVNTVLSSCGFPS	FSIP2	3331	Q5CZC0
FTLSQEVGCQPLQTL	LENG9	466	Q96B70
TFIAVPASNSGLCIV	NXF1	516	Q9UBU9
PASNSGLCIVNDELF	NXF1	521	Q9UBU9
GPVEVSTLQCLANAT	NPEPL1	161	Q8NDH3
IPCTAQEALTAQGLS	PDE4A	726	P27815
GLDFSLQSPTQVADC	PEX7	291	O00628
NPETCQLFTTELGRA	EEF2KMT	286	Q96G04
TFLQQLCPDSGTIAA	GALK1	151	P51570
SLLPVVNNSGAICNS	MED23	226	Q9ULK4
VCLSFNPQSTLVATG	DAW1	181	Q8N136
GCNSAFLSVPLTNLT	PINLYP	106	A6NC86
LNSPTICQTFVGRAL	HERVK_113	166	P63132
EVPFGTNCNLTITSR	LY75	521	O60449
IGVVSATFSLCQPAQ	TUBGCP6	361	Q96RT7
PQCFSLRTEQGTVLI	ELP1	21	O95163
QAQSRAIPFVGCLTQ	OR1I1	86	O60431
SVIQSTFTLQLPLCG	OR2C1	156	O95371
QAVLNGVCTFFTAVP	OR2C1	196	O95371
QEISIGTQISCFSPS	PANX1	56	Q96RD7
LVICSGISNQPLEFT	DDX11	661	Q96FC9
SGFEVPQVLQSCTAF	ARHGAP32	381	A7KAX9
TFSFPCQQTSLDAGI	HK1	601	P19367
LNSPTICQTFVGRAL	ERVK-7	166	P63135
LNSPTICQTFVGRAL	ERVK-6	166	Q9BXR3
PSGEVNTNVAFCSVL	DXO	206	O77932
NLVGAFVCQSTIIPS	ELAPOR2	751	A8MWY0
NLSGNCFQEVPASLL	LRRC58	126	Q96CX6
NIGCANQFSSTAPVL	RELN	1306	P78509
VAELVFANCPLNGTS	MED14	721	O60244
LSLADLCFSTNIVPQ	OR2D2	66	Q9H210
LTCPEVSAFAGAQRT	FOSB	306	P53539
IQERSLCVASPGFNV	PFN4	26	Q8NHR9
LNSPTICQTFVGRAL	ERVK-18	166	Q9QC07
NTLTGQPLQCIDTGS	FZR1	386	Q9UM11
ITNPLAVLCEFISQS	APOB	3186	P04114
PQGFAAIRVTLCSNT	HYDIN	651	Q4G0P3
FPNRQCLTTVIDISG	CC2D2A	1281	Q9P2K1
PVGCVSFQNISSNVL	DOCK6	1641	Q96HP0
LPVGCVTFQNISSNV	DOCK7	1731	Q96N67
CFNTLTNSFQPSLLG	ADAR	851	P55265
TSSVAVGCLAQDFLP	IGHM	21	P01871
DFIPGSDQLNVISCQ	COL6A1	761	P12109
TFTELANIAIPQCGV	C16orf96	6	A6NNT2
GTELSLNPTCAVFIT	DNAH3	1516	Q8TD57
CFSPNRVIGLSSDLQ	EIF3F	256	O00303
CGKTTQIPQFILDDS	DHX57	571	Q6P158
SEQLVFNSVTNCLGP	ITSN1	1446	Q15811
TQVLSGFQGCLDSVI	FAT3	3976	Q8TDW7
SVGGICQQFSLPENI	FOXRED1	111	Q96CU9
SCLGIVNEELPSINT	IL23R	596	Q5VWK5
LSLCSTQPDGNVVIA	IGHA1	11	P01876
VICSGVSNQPLEFTF	DDX12P	681	Q92771
ALATPDTLQGQCSAF	ABCA2	391	Q9BZC7
AITIDGVTPLFNACS	ASB5	131	Q8WWX0
VQLLTPCSAQFSVLG	BTN3A2	21	P78410
ICARVDASFQPQGSL	ITGA10	141	O75578
AVFCPNLTEVSSTGN	FPGS	436	Q05932
LEPSNVGNLSFSCVE	CNTNAP2	356	Q9UHC6
TTNQGDCPLIVQFAA	DUS4L	76	O95620
LVCLVSDFNPGAVTV	IGLC7	26	A0M8Q6
PFILNVTSGALLCSQ	HYAL1	346	Q12794
LCALVSAQFTVVGPA	BTN2A2	26	Q8WVV5
FVPEGTQILCTAQAA	SLC22A20P	416	A6NK97
PGSSIVTEFNLVCAN	SLC22A2	131	O15244
QFSGPEIQFLLSCSE	RYR1	4101	P21817
VGPSVLNFGNICVNS	CFAP47	751	Q6ZTR5
QVSPSLLNVCFLSTG	IFT140	421	Q96RY7
NSGFPEDCLLTQVFT	DHX9	966	Q08211
ALNSCSIPVSVEAFL	DPPA2	201	Q7Z7J5
SQVLSINLFGNPLTC	LRRN4	301	Q8WUT4
TTQCLPTAIFAATGI	P2RY6	156	Q15077
SIVENCFGAAGQPLT	PLEKHF2	16	Q9H8W4
GASCVVPESNFNNIL	SLC10A2	16	Q12908
SGTFTVTLQNAPCGL	OTOG	546	Q6ZRI0
PAFSLCSQVIVGSAV	MOXD2P	266	A6NHM9
ICFTTSLAPQTLVNL	OR2G3	71	Q8NGZ4
IFTGLFQDPAVQSVC	OR4B1	11	Q8NGF8
VVFLCLSTVNGVADP	GPR132	291	Q9UNW8
ITFECAQISGSPAFQ	IGF2R	1186	P11717
GCALVQLQPLTVFSS	RPUSD3	231	Q6P087
QLSLPQFCVSILESA	RTTN	376	Q86VV8
CTSSEPFLGQTLQAA	USH2A	3666	O75445
ICSLFGEAPQNLSQT	USP9X	576	Q93008
CGSLQLVFSPNEEIT	USP9X	1251	Q93008
GLCDFRLQAPQASVT	RAB11FIP1	1026	Q6WKZ4
STCVDIPDAIFGQLN	TIGD6	481	Q17RP2
CLIAQTTPVAGSQSL	SRRM2	2461	Q9UQ35
HSLSFETQLCQPGLV	STAT1	431	P42224
SGLFTVSAQNLPCGA	SSPOP	1046	A2VEC9
EFSPVDNCLQSVLGQ	STRIP2	786	Q9ULQ0
RQASQLSLESTVGPC	RIMS4	251	Q9H426
LQLAISNTCAAFAPT	SLC22A24	181	Q8N4F4
VSRNLPSSFLQQTCG	MAP3K21	861	Q5TCX8
FTQGECPSANVAVLG	NCKAP5	1391	O14513
TAQVLSFLEPCTQQG	SPATA31A6	781	Q5VVP1
CSGLGVSNPVEFILN	NSUN7	376	Q8NE18
SSVAPNTLVNFLCEV	OR5AL1	91	P0C617
ILNFSPQQVAGVCET	SIX6	6	O95475
NILIPGTLESGCFQN	SIGLEC7	151	Q9Y286
ILANTSDNAGFCIPE	SCARB2	301	Q14108
ISVNIQDLAPSCAGF	SLC17A9	356	Q9BYT1
TFNLPSAAASVQCLA	WDR17	261	Q8IZU2
NVQLLSQFVSPFTGC	MRPS18C	76	Q9Y3D5
LLTTFANVVNVCGNP	RNASE2	71	P10153
VDATLIPITNFSCGI	SLC25A38	211	Q96DW6
NCNPSLLSIIGYNTT	SERINC1	286	Q9NRX5
LPQTSSGCAENLEFT	AKAP6	2231	Q13023
AASQLTFPAVTLCNL	ASIC1	81	P78348
LNSPTICQTFVGRAL	ERVK-25	166	P63136
ACVPFALVSQLQGQT	SLC49A3	326	Q6UXD7
PVDSSGDQQLCFVLT	SPG11	471	Q96JI7
CPVVVSAGNSELSLQ	SNX17	286	Q15036
IPGSAVCAFDLTQVA	SEMA6B	331	Q9H3T3
VSLGFVISNPDLVTC	ZNF595	41	Q8IYB9
CQGNAPALATVSLAT	ZNF341	76	Q9BYN7
SSGNPTVQTLACSIL	XPO4	146	Q9C0E2
AVTNGVLPSVQSFSC	SLC52A1	291	Q9NWF4
CIELVQVPGQSSIFT	TMEM94	766	Q12767
GQLNSLPCSLTFRQE	TMEM94	1056	Q12767
GDCNFVAPQGISSII	RNLS	101	Q5VYX0
ATDNFLCTVTPGLIN	SAGE2P	356	A6NJ88
GPQLRDFSSIIQTCS	STX12	16	Q86Y82
TCLINQTLSFNGTSP	SLCO1B3	141	Q9NPD5
LNSPTICQTFVGRAL	ERVK-10	166	P10266
LNSPTICQTFVGRAL	ERVK-8	166	P63133
NTAQGRFDTSILPIC	SPOCK1	231	Q08629
TALNFSDTVGAVCLP	TMPRSS5	316	Q9H3S3
LQDTVVPLFSTQLCN	TMPRSS5	361	Q9H3S3
SGLCIPANNTLFIVS	NF1	1896	P21359
LGSASNQFCLPVLDS	PHF3	56	Q92576
LNSPTICQTFVGRAL	ERVK-11	166	Q9UQG0
LGLVVQNFCSPAETT	STAB2	11	Q8WWQ8
LTEIQSLTFNPTAGC	TSLP	76	Q969D9
QSTFCEVPLLNSLTV	TECPR2	636	O15040
ENTVLLGSIPCNVTS	PKHD1L1	1361	Q86WI1
FDRPNCVALGVTSIS	PKHD1L1	2746	Q86WI1
NSSFPFCIGVAILQQ	TBCK	651	Q8TEA7
ITENTSIPTRGLCNF	GTF3C4	701	Q9UKN8
IVSIPANIGSLCVSF	GPR65	26	Q8IYL9
INNFCEGSISASPLN	RNF168	186	Q8IYW5
VLVQTLCEPASIGFN	PRKDC	1371	P78527
SALTSPQCLGQQAFA	ZMIZ2	81	Q8NF64
ASRLECSTLVNGQAP	ZNF608	901	Q9ULD9
QYSSLGSQPILCASI	WNT3A	31	P56704
IIFGNEQIISSASPC	TRAPPC8	1181	Q9Y2L5
FCLLQAGPLDTAVSQ	TRBV3-1	11	A0A576
PALCDTLITVGSQEF	ZBTB32	26	Q9Y2Y4
QGESRVPLTLCSNAA	ZBTB2	286	Q8N680
VVIPCLGSISNLNVS	KDR	146	P35968
CISSATGLIENRPQS	WASF1	296	Q92558
LSLCLQDSFPLTVQS	THSD7B	316	Q9C0I4
SCPLAFGSQQFLSQD	ZNF589	86	Q86UQ0
ASKEPVGCVNNISFL	ZFAND4	556	Q86XD8
LQPTEDCVFTALGIN	RAPGEFL1	376	Q9UHV5
FTTQLNSIPGSAVCA	SEMA6D	316	Q8NFY4
VIQFVGACLNDPSQF	TNNI3K	521	Q59H18
GACLNDPSQFAIVTQ	TNNI3K	526	Q59H18
IGPDLIQNCITVTSA	ZNF335	141	Q9H4Z2
SVPEGENLVLNCSFT	TRAV21	31	A0A0B4J279
GSPLQNQTACIGVLF	UHRF1BP1	861	Q6BDS2
NQTACIGVLFPSAEV	UHRF1BP1	866	Q6BDS2
PSQLDLCEQVFGLSA	PRSS16	401	Q9NQE7
SVPIQEGQSLFLACT	SIGLEC14	261	Q08ET2
EGQSLFLACTVDSNP	SIGLEC14	266	Q08ET2
SIPVNAFQGLCNETL	TSHR	166	P16473